Masaaki Miyauchi Masao Toyoda Masafumi Fukagawa
10.2169/internalmedicine.56.7945
Intern Med
2017;56(13):1673-1678.
sglt2 inhibitor ipragliflozin ketoacidosis protracted hyperglycosuria
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28674356/
Glucosides / adverse effects Hypoglycemic Agents / adverse effects Ketosis / chemically induced Thiophenes / adverse effects
Glucosides / adverse effects Hypoglycemic Agents / adverse effects Ketosis / chemically induced Thiophenes / adverse effects Case Reports Diabetes Mellitus, Type 2 / complications Diabetes Mellitus, Type 2 / drug therapy Diabetes Mellitus, Type 2 / urine Female Humans Hypoglycemic Agents / therapeutic use Obesity / complications Sodium-Glucose Transporter 2 Sodium-Glucose Transporter 2 Inhibitors Young Adult Glucosides Hypoglycemic Agents SLC5A2 protein, human Sodium-Glucose Transporter 2 Sodium-Glucose Transporter 2 Inhibitors Thiophenes ipragliflozin
PMC5519469
28674356
Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor
2017